The effect of mannitol infusion on the response to diuretic therapy in cirrhotic patients with ascites

Journal of Clinical Gastroenterology

Volumn 35, Issue 5, 2002, Pages 403-405

  Pamuk, Ömer Nuri ^a   Sonsuz, Abdullah ^a  

^a NONE   (Turkey)

Author keywords

Ascites; Diuretics; Liver cirrhosis; Mannitol

Indexed keywords

DIURETIC AGENT; FUROSEMIDE; GLUCOSE; MANNITOL; POTASSIUM ION; SODIUM ION; SPIRONOLACTONE;

ARTICLE; ASCITES; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURETIC THERAPY; DRUG INFUSION; HUMAN; LIVER CIRRHOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; TREATMENT OUTCOME; URINE VOLUME;

ASCITES; DISEASE PROGRESSION; DIURETICS, OSMOTIC; DRUG RESISTANCE; ELECTROLYTES; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MANNITOL; MIDDLE AGED; TREATMENT OUTCOME; URINE;

EID: 0036840335     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200211000-00009     Document Type: Article

References (14)

1. Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: Natural history and prognostic factors. Hepatology 1987;7:122-8.
2. D'amico G, Morabito A, Pagliora L, et al. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986;31:468-75.
3. Runyon BA. Care of patients with ascites. N Engl J Med 1994;330:337-42.
4. Arroyo V, Epstein M, Gallus G, et al. Refractory ascites in cirrhosis: Mechanism and treatment. Gastroenterol Int 1989;2:195-207.
5. Henriksen JH, Ring-Larsen H. Ascites formation in liver cirrhosis: the how and the why. Dig Dis 1990;8:152.
6. Arroyo V, Rodes J. A rational approach to the treatment of ascites. Postgrad Med J 1975;51:558-62.
7. Vita MC, Coll S, Sola R, et al. Total paracentesis in cirrhotic patients with tense ascites and ditutional hyponatremia. Am J Gastroenterol 1999;94:2219-23.
8. Panos MZ, Moore K, Vtavianos P, et al. Single, total paracentesis for tense ascites: Sequential hemodynamic changes and right atrial size. Hepatology 1990; 11:662-7.
9. Warren SE, Blantz RC. Mannitol. Arch Intern Med 1981;141:493-7.
10. Fernandez-Cruz A, Marco J, Cuadrado LM, et al. Plasma levels of atrial natriuretic peptide in cirrhotic patients. Lancet 1985;2:1439-40.
11. Salerno F, Badalamenti S, Incerti P, et al. Renal response to atrial natriuretic peptide in patients with advanced liver cirrhosis. Hepatology 1988;8:21-6.
12. Morali GA, Tobe SW, Skorecki KL, et al. Refractory ascites: Modulation of atrial natriuretic factor unresponsiveness by mannitol. Hepatology 1992;16:42-8.
13. Abraham WT, Lauwaars ME, Kim JK, et al. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis. Hepatology 1995;22:737-43.
14. Levy M, Richard C. Mobilization of ascites in cirrhotic dogs following furosemide or mannitol diuresis. Am J Physiol 1978;235:12-21.